In this study, we observed for the first time that the expression level of PHLDA2 was up-regulated, consistent with the majority of cancers, including liver cancer, colorectal cancer, glioma, lung cancer [17–19, 33]. This evidence concerns the gene PHLDA2 and lung carcinoma.